171 related articles for article (PubMed ID: 12728859)
1. $15 million for infrastructure but no AIDS drugs for Jamaica.
GMHC Treat Issues; 2003 Mar; 17(3):9-10. PubMed ID: 12728859
[No Abstract] [Full Text] [Related]
2. Time to move on HIV/AIDS treatment and care.
Schwartländer B; Lange JM
IAPAC Mon; 2003 Jan; 9(1):6-7. PubMed ID: 12712942
[No Abstract] [Full Text] [Related]
3. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
4. Therapies. The high cost of poverty.
Cohen J
Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
[No Abstract] [Full Text] [Related]
5. Funding for HIV/AIDS needs to double to ensure universal access to drugs.
Dyer C
BMJ; 2009 Feb; 338():b583. PubMed ID: 19211637
[No Abstract] [Full Text] [Related]
6. Drug companies, UNAIDS make drugs available.
AIDS Alert; 1998 Jan; 13(1):3. PubMed ID: 11364863
[TBL] [Abstract][Full Text] [Related]
7. Ensuring access to essential medicines: some economic considerations.
Maskus KE
Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
[No Abstract] [Full Text] [Related]
8. Africa: interview with South African High Court Justice Edwin Cameron. Interviewing by Bruce Mirken.
Cameron E
AIDS Treat News; 2001 Jul; (368):4-7. PubMed ID: 11547443
[No Abstract] [Full Text] [Related]
9. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
Kazatchkine M; Moatti JP
Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
[No Abstract] [Full Text] [Related]
10. ADAP programs fight for survival with less money and more clients. North Carolina's list tops 700 by midyear.
AIDS Alert; 2004 Aug; 19(8):85, 87-9. PubMed ID: 15300944
[TBL] [Abstract][Full Text] [Related]
11. Wealthy nations called on to boost support efforts. Five-year plan estimated to cost $9.2 billion.
Annan K; Piot P; Schwartlander B; Berman D; Davis P; Kaninda AV; Ouma C; Leghentsev K
AIDS Alert; 2001 Aug; 16(8):99-101. PubMed ID: 11547707
[TBL] [Abstract][Full Text] [Related]
12. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
13. The promise of ADAP.
Montgomery M
Focus; 2007 Jan; 22(1):4-6. PubMed ID: 17526106
[No Abstract] [Full Text] [Related]
14. HHS announces $710 million in grants for HIV/AIDS care.
Sweeney R; Rose VL
Am Fam Physician; 1999 May; 59(9):2403. PubMed ID: 10323349
[No Abstract] [Full Text] [Related]
15. ADAP fund officials predict shortfall that threatens lives of HIV patients. Congress can fix funding shortage with a $90 million infusion.
AIDS Alert; 1999 Sep; 14(9):97-101. PubMed ID: 15386844
[No Abstract] [Full Text] [Related]
16. HIV/AIDS. The high cost of stolen funds.
Cohen J
Science; 2008 Jul; 321(5888):523. PubMed ID: 18653880
[No Abstract] [Full Text] [Related]
17. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
Maher D; von Schoen-Angerer T; Cohn J
Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
[No Abstract] [Full Text] [Related]
18. HIV/AIDS. Botswana's success comes at steep cost.
Cohen J
Science; 2008 Jul; 321(5888):526-9. PubMed ID: 18653882
[No Abstract] [Full Text] [Related]
19. World AIDS Day 2003.
Fauci AS
IAPAC Mon; 2003 Dec; 9(12):319. PubMed ID: 15055167
[No Abstract] [Full Text] [Related]
20. Kenya says yes to generic ARVs but fails to win Global Fund cash.
Njoroge J
Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
[No Abstract] [Full Text] [Related]
[Next] [New Search]
